Irhythm Technologies [IRTC] vs Bio-Rad Laboratories [BIO] Detailed Stock Comparison

Irhythm Technologies Inc.

NASDAQ
Loading...

Bio-Rad Laboratories Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Irhythm Technologies Inc. wins in 2 metrics, Bio-Rad Laboratories Inc. wins in 18 metrics, with 0 ties. Bio-Rad Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Irhythm Technologies Inc. Bio-Rad Laboratories Inc. Better
P/E Ratio (TTM) -87.47 10.98 Bio-Rad Laboratories Inc.
Price-to-Book Ratio 25.14 1.11 Bio-Rad Laboratories Inc.
Debt-to-Equity Ratio 478.69 18.58 Bio-Rad Laboratories Inc.
PEG Ratio 0.17 -0.05 Irhythm Technologies Inc.
EV/EBITDA -130.50 18.75 Bio-Rad Laboratories Inc.
Profit Margin (TTM) -5.96% 29.42% Bio-Rad Laboratories Inc.
Operating Margin (TTM) 4.20% 8.87% Bio-Rad Laboratories Inc.
EBITDA Margin (TTM) 4.20% 8.87% Bio-Rad Laboratories Inc.
Return on Equity -36.57% 10.84% Bio-Rad Laboratories Inc.
Return on Assets (TTM) -2.36% 1.67% Bio-Rad Laboratories Inc.
Free Cash Flow (TTM) $34.52M $374.60M Bio-Rad Laboratories Inc.
1-Year Return -18.93% 37.70% Bio-Rad Laboratories Inc.
Price-to-Sales Ratio (TTM) 5.23 3.20 Bio-Rad Laboratories Inc.
Enterprise Value $3.99B $8.09B Bio-Rad Laboratories Inc.
EV/Revenue Ratio 5.34 3.13 Bio-Rad Laboratories Inc.
Gross Profit Margin (TTM) 70.88% 49.80% Irhythm Technologies Inc.
Revenue per Share (TTM) $23 $95 Bio-Rad Laboratories Inc.
Earnings per Share (Diluted) $-1.39 $27.85 Bio-Rad Laboratories Inc.
Beta (Stock Volatility) 1.18 1.16 Bio-Rad Laboratories Inc.
Short % of Float 10.20% 0.00% Bio-Rad Laboratories Inc.

Irhythm Technologies Inc. vs Bio-Rad Laboratories Inc. Stock Performance Analysis

Loading Price Chart...

IRTC
BIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Irhythm Technologies Inc.2.67%-6.13%-12.27%-16.92%-42.88%-40.33%
Bio-Rad Laboratories Inc.0.87%-0.15%18.22%8.79%-4.84%-0.14%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Irhythm Technologies Inc.-18.93%7.80%83.44%341.64%341.64%341.64%
Bio-Rad Laboratories Inc.37.70%-16.08%-46.24%110.71%155.96%366.11%

Performance & Financial Health Analysis: Irhythm Technologies Inc. vs Bio-Rad Laboratories Inc.

MetricIRTCBIO
Market Information
Market Cap i$3.99B$7.60B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i379,433239,625
90 Day Avg. Volume i483,824284,785
Last Close$107.35$307.47
52 Week Range$101.75 - $212.00$218.14 - $343.12
% from 52W High-49.36%-10.39%
All-Time High$286.19 (Jan 25, 2021)$832.70 (Aug 30, 2021)
% from All-Time High-62.49%-63.08%
Growth Metrics
Quarterly Revenue Growth0.27%0.04%
Quarterly Earnings Growth0.27%0.04%
Financial Health
Profit Margin (TTM) i-0.06%0.29%
Operating Margin (TTM) i0.04%0.09%
Return on Equity (TTM) i-0.37%0.11%
Debt to Equity (MRQ) i478.6918.58
Cash & Liquidity
Book Value per Share (MRQ)$4.73$276.16
Cash per Share (MRQ)$18.06$57.08
Operating Cash Flow (TTM) i$80.86M$532.20M
Levered Free Cash Flow (TTM) i$71.67M$256.55M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Irhythm Technologies Inc. vs Bio-Rad Laboratories Inc.

MetricIRTC (Apr 24, 2026)BIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-87.4710.98
Forward P/E i142.1426.94
PEG Ratio i0.17-0.05
Price to Sales (TTM) i5.233.20
Price to Book (MRQ) i25.141.11
Market Capitalization
Market Capitalization i$3.99B$7.60B
Enterprise Value i$3.99B$8.09B
Enterprise Value Metrics
Enterprise to Revenue i5.343.13
Enterprise to EBITDA i-130.5018.75
Risk & Other Metrics
Beta i1.181.16
Book Value per Share (MRQ) i$4.73$276.16

Financial Statements Comparison: Irhythm Technologies Inc. vs Bio-Rad Laboratories Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIRTC (2025)BIO (2025)
Revenue/Sales i747.14M2.58B
Cost of Goods Sold i219.89M1.24B
COGS % of Revenue i29.4%48.1%
Gross Profit i527.25M1.34B
Gross Margin i70.6%51.9%
Research & Development i84.61M275.60M
Operating Income (EBIT) i-49.91M218.60M
Operating Margin i-6.7%8.5%
EBITDA i3.53M480.70M
EBITDA Margin i0.5%18.6%
Pre-Tax Income i-43.60M995.50M
Pre-Tax Income % of Revenue i-5.8%38.5%
Income Tax i953,000235.60M
Income Tax % of Revenue i0.1%9.1%
Net Income (Profit) i-44.55M759.90M
Profit Margin i-6.0%29.4%

Balance Sheet & Liquidity Metrics

MetricIRTC (2025)BIO (2025)
Cash & Equivalents i236.01M529.80M
Total Current Assets i702.77M2.91B
Total Current Assets % of Revenue i94.1%112.5%
Total Current Liabilities i151.89M517.00M
Total Current Liabilities % of Revenue i20.3%20.0%
Long-Term Debt i714.50M1.35B
Long-Term Debt % of Revenue i95.6%52.2%
Total Shareholders Equity i152.75M7.45B
Retained Earnings i-803.45M8.18B
Retained Earnings % of Revenue i-107.5%316.5%
Property, Plant & Equipment i59.45M1.49B

Cash Flow Statement Comparison

MetricIRTC (2025)BIO (2025)
Operating Cash Flow i-37.09M1.25B
Operating Cash Flow % of Revenue i-5.0%48.4%
Capital Expenditures i-46.34M-157.50M
Free Cash Flow i34.52M374.60M
FCF Margin i4.6%14.5%
Debt Repayment i0-500,000
Common Stock Repurchase i0-295.50M

Short Interest & Institutional Ownership Analysis

MetricIRTCBIO
Shares Short i2.94M26
Short Ratio i4.570.00
Short % of Float i10.20%0.00%
Shares Outstanding i32.30M26.99M
Float Shares i30.29M21.13M
% Held by Insiders i1.23%16.20%
% Held by Institutions i112.51%91.50%
% Held by Public i-13.74%-7.70%

Dividend Analysis & Yield Comparison: Irhythm Technologies Inc. vs Bio-Rad Laboratories Inc.

MetricIRTCBIO
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A